Anti-Monopoly

The Justice Department plays a key role in President Biden’s vision of promoting “the interests of American workers, businesses, and consumers” through increasing competition, a plan which stands to be one the most enduring legacies of this administration. Your commitment to promote “competition by fairly and vigorously enforcing the antitrust laws,” along with the confirmation of Jonathan Kanter to Assistant Attorney General for the Antitrust Division, are crucial steps forward in this vision.

Since the Copyright Office provides expert recommendations and advice to Congress, the executive branch, and the courts, Disney’s recent employees may soon be advising government officials about copyright policy.

In theory, nothing prevents Biden from hiring whomever Kanter personally trusts to help execute their shared agenda. So what’s causing the chaos?

One tiny federal agency with 116 full-time employees and a $28.9 million dollar budget is in charge of regulating the global marine economy, which contributes $397 billion to the US GDP annually and accounts for 80 percent of goods shipped worldwide. That’s not just an apples and oranges discrepancy—that’s like an apple versus Apple. The budget for the military’s marching bands is fifteen times greater than the Federal Maritime Commission’s budget; the Marines alone have five times more musicians than the Commission has staff.

On November 2, the Revolving Door Project led a coalition of seven organizations in a letter to Penn Law Dean Theodore Ruger. The letter calls on the law school to require its faculty to “clearly disclose any compensation or funding they receive from companies, either direct or indirect (e.g., from a foundation or organization largely funded by a corporation or corporate officer associated with a specific corporation with a stake in the work in question).”

It was never a secret that Attorney General Merrick Garland was among the key Biden administration figures opposing Jonathan Kanter’s nomination as assistant attorney general for antitrust. Ultimately, however, Garland did not get his way; the appointment went to Kanter rather than to one of the many Big Tech–allied BigLaw partners whom Garland favored. In view of Kanter’s career as a plaintiff’s lawyer, his nomination was rightly celebrated as a decisive victory by antitrust reformers and BigLaw opponents alike. But it was just one battle in a broader war for renewed anti-monopoly enforcement and a DOJ eager to build back better in every policy area.

Facebook continues to lie to the public with abandon. That is one of the main takeaways from the Facebook whistleblower’s testimony last week. Even now, having been called out, Facebook is frantically working to obscure and underplay its own dishonesty. 

We write to you as a broad coalition of organizations committed to holding corporations that engage in anti-competitive behavior accountable. For far too long, Washington has sat by as technology industry giants have accumulated monopoly power at the expense of consumers and competitors alike. The nomination of Jonathan Kanter to serve as Assistant Attorney General for the Department of Justice Antitrust Division is a strong step toward turning President Joe Biden’s vision of an open economy into reality.

Economic consulting firms hire former officials to undermine antitrust efforts. Here’s how to stop that.

The letter calls on the university to implement fair disclosure requirements for its faculty and condemn the unethical practices of former Pritzker Dean Dr. Daniel Rodriguez.

In a move cheered by progressives and antitrust reformers, President Biden has nominated Jonathan Kanter to serve as assistant attorney general for antitrust. Kanter’s nomination, alongside that of Lina Khan to lead the Federal Trade Commission earlier this year, is the latest sign that this administration is, for the first time in generations, fiercely committed to enforcing antitrust laws. However, this generation’s most notorious monopolies—Amazon, Facebook, and Google—are making it vividly clear that they will try anything to retain their power. That apparently includes lobbing poorly reasoned, transparently bad faith calls for their newly anointed foes to recuse themselves from relevant cases.

Personnel vacancies and Big Pharma allies in the Biden administration threaten a landmark executive order on competition.

The administration’s staffing vacancies could undermine Biden’s promise to help family farms fight Big Ag monopolies.

In 2019, Gallup found that the pharmaceutical industry was “the most poorly regarded industry in Americans’ eyes,” and rightfully so. Pharmaceutical companies often set drug prices exorbitantly high, including life-saving drugs which patients literally cannot go without, such as insulin. This includes older drugs that are cheaper to produce — such as epinephrine (emergency medication used to treat severe allergic reactions and asthma attacks). These firms achieve this by stifling competition at the consumer’s expense, jealously protecting their money-makers from the generics which the pharmaceutical system is supposed to develop after a patent expires.

Numerous positions are vacant, threatening progress in a host of areas.